Skip to main content
SpringerLink
Log in

Pediatric Drug Development and the Regulatory Changes That Are Creating the Science of Pediatric Dosing

  • Chapter
  • First Online:
Fundamentals of Pediatric Drug Dosing

  • 1142 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 149.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shirkey H (1999) Editorial comment: therapeutic orphans. Pediatrics 104:583–584

    CAS  PubMed  Google Scholar 

  2. Shirkey HC, editor. Pediatric dosage handbook. Washington, DC: American Pharmaceutical Association; 1965.

    Google Scholar 

  3. Jusko WJ, Khanna N, Levy G, Stern L, Yaffe SJ (1970) Riboflavin absorption and excretion in the neonate. Pediatrics 45:945–949

    CAS  PubMed  Google Scholar 

  4. Jusko WJ, Mosovich LL, Gerbracht LM, Mattar ME, Yaffe SJ (1975) Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics 56:1038–1044

    CAS  PubMed  Google Scholar 

  5. Jusko WJ, Baliah T, Kim KH, Gerbracht LM, Yaffe SJ (1976) Pharmacokinetics of gentamicin during peritoneal dialysis in children. Kidney Int 9:430–438

    Article  CAS  PubMed  Google Scholar 

  6. Yaffe SJ, Rane A (1971) Developmental aspects of pharmacokinetics. Acta Pharmacol Toxicol 29(Suppl 3):240–249

    CAS  Google Scholar 

  7. Momper JD, Mulugeta Y, Burckart GJ (2015) Failed pediatric drug development trials. Clin Pharmacol Therapeutics 98:245–51

    Article  CAS  Google Scholar 

  8. Mulugeta Y, Barrett JS, Nelson R, Eshete A, Mushtaq A, Yao L,Glasgow N, Mulberg A, Green D, Florian J, Krudys K, Seo S, Kim I,Chilukuri D, Burckart GJ.Exposure matching criteria for extrapolation of efficacy in pediatric drug development. Journal of Clinical Pharmacology 2016 Apr 4. doi: 10.1002/jcph.744

    Google Scholar 

  9. Momper JD et al (2007) Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of. JAMA Pediatr 167:926–932

    Article  Google Scholar 

  10. Green D, Mummaneni P, Kim IW, Oh JM, Pacanowski M, Burckart GJ. Pharmacogenomic information in FDA-approved drug labels: application to pediatric – patients. Clin Pharmacol Therap. 2015; doi:10.1002/cpt.330.

    Google Scholar 

  11. Newcorn JH et al (2009) Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder. J Am Acad Child Adolescent Psychiatry 48:1165–1172

    Article  Google Scholar 

  12. Fernandes R, Ferreira JJ, Sampaio C (2008) The placebo response in studies of acute migraine. J Pediatr 152:527–33

    Article  PubMed  Google Scholar 

  13. Benninga MA, Mayer EA (2009) The power of placebo in pediatric functional gastrointestinal disease. Gastroenterology 137:1207–1210

    Article  PubMed  Google Scholar 

  14. Finkelstein Y, Nurmohamed L, Avner M, Benson LN, Koren G (2005) Clopidogrel use in children. J Pediatr 147:657–661

    Article  CAS  PubMed  Google Scholar 

  15. Li JS et al (2008) Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trial. Circulation 117:553–559

    Article  CAS  PubMed  Google Scholar 

  16. Caruthers RL, Dorsch MP. Letter by Caruthers and Dorsch regarding article, Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the platelet inhibition in children on cLOpidogrel (PICOLO) trial. Circulation. 2008;118:e120; author reply e121.

    Google Scholar 

  17. Leto Di Priolo S, Priore P, Cocco G, Sfrisi C, Cazor JL (1988) Dose-titration study of alfuzosin, a new alpha 1-adrenoceptor blocker, in essential hypertension. Eur J Clin Pharmacol 35:25–30

    Article  CAS  PubMed  Google Scholar 

  18. Ahonen K, Hamalainen ML, Eerola M, Hoppu K (2006) A randomized trial of rizatriptan in migraine attacks in children. Neurology 67:1135–1140

    Article  CAS  PubMed  Google Scholar 

  19. Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J (2006) Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache 46:101–109

    Article  PubMed  Google Scholar 

  20. Institute of Medicine: safe and effective medicines for children: pediatric studies conducted under BPCA and PREA. 2012. Access at: http://iom.edu/Reports/2012/Safe-and-Effective-Medicines-for-Children.aspx.

Download references

Author information

Authors and Affiliations

  1. Associate Director for Pediatrics, Office of Clinical Pharmacology, Office of Translational Sciences, CDER, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA

    Gilbert J. Burckart PharmD

Authors
  1. Gilbert J. Burckart PharmD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinical Pharmacology/Biopharmaceutics, Food & Drug Administration, Silver Spring, Maryland, USA

    Iftekhar Mahmood

  2. Clinical Pharmacology, Food & Drug Administration, Pediatric Group, Silver Spring, Maryland, USA

    Gilbert Burckart

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Burckart, G.J. (2016). Pediatric Drug Development and the Regulatory Changes That Are Creating the Science of Pediatric Dosing. In: Mahmood, I., Burckart, G. (eds) Fundamentals of Pediatric Drug Dosing. Adis, Cham. https://doi.org/10.1007/978-3-319-43754-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43754-5_1

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-43752-1

  • Online ISBN: 978-3-319-43754-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation